Elizabeth Schramm

Elizabeth Schramm has worked for a number of companies since 2001. Elizabeth began their career as a Research Assistant at the University of Kansas Medical Center and then moved to Kansas State University as a Research Associate in 2003. In 2012, they became a Postdoctoral Research Associate at Washington University in St. Louis. In 2015, they joined Serion as a Scientist and in 2017 was promoted to Chief Technology Officer of Serion, Inc. In 2016, they became the Director of Research at AnthroBio, Inc. and in 2018, they were appointed Director of Research and Development, Director of Preclinical Science, and Senior Scientist at OpenCell Technologies, Inc. In 2021, they were appointed Director of NK Research at Wugen.

Elizabeth Schramm obtained a Bachelor of Science (BS) in Biology, General from Kansas State University between 1996 and 2001. Elizabeth then went on to pursue a Doctor of Philosophy (PhD) in Immunology from Washington University in St. Louis, which they completed in 2012.